» Articles » PMID: 16793338

Motor Cortical Excitability Studied with Repetitive Transcranial Magnetic Stimulation in Patients with Huntington's Disease

Overview
Publisher Elsevier
Specialties Neurology
Psychiatry
Date 2006 Jun 24
PMID 16793338
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: TMS techniques have provided controversial information on motor cortical function in Huntington's disease (HD). We investigated the excitability of motor cortex in patients with HD using repetitive transcranial magnetic stimulation (rTMS).

Methods: Eleven patients with HD, and 11 age-matched healthy subjects participated in the study. The clinical features of patients with HD were evaluated with the United Huntington's Disease Rating Scale (UHDRS). rTMS was delivered with a Magstim Repetitive Magnetic Stimulator through a figure-of-8 coil placed over the motor area of the first dorsal interosseus (FDI) muscle. Trains of 10 stimuli were delivered at 5 Hz frequency and suprathreshold intensity (120% resting motor threshold) with the subjects at rest and during voluntary contraction of the target muscle.

Results: In healthy subjects at rest, rTMS produced motor evoked potentials (MEPs) that increased in amplitude over the course of the trains. Conversely in patients, rTMS left the MEP size almost unchanged. In both groups, during voluntary contraction rTMS increased the silent period (SP) duration.

Conclusions: Because rTMS modulates motor cortical excitability by activating cortical excitatory and inhibitory interneurons these findings suggest that in patients with HD the excitability of facilitatory intracortical interneurones is decreased.

Significance: We suggest that depressed excitability of the motor cortex in patients with HD reflects a disease-related weakening of cortical facilitatory mechanisms.

Citing Articles

Transcranial magnetic stimulation in animal models of neurodegeneration.

Uzair M, Abualait T, Arshad M, Yoo W, Mir A, Bunyan R Neural Regen Res. 2021; 17(2):251-265.

PMID: 34269184 PMC: 8464007. DOI: 10.4103/1673-5374.317962.


Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis.

Menculini G, Chipi E, Paoletti F, Gaetani L, Nigro P, Simoni S Int J Mol Sci. 2021; 22(9).

PMID: 33922780 PMC: 8123079. DOI: 10.3390/ijms22094440.


Use of transcranial magnetic stimulation in the treatment of selected movement disorders.

Brown K, Neva J, Ledwell N, Boyd L Degener Neurol Neuromuscul Dis. 2020; 4:133-151.

PMID: 32669907 PMC: 7337234. DOI: 10.2147/DNND.S70079.


Hyperkinetic disorders and loss of synaptic downscaling.

Calabresi P, Pisani A, Rothwell J, Ghiglieri V, Obeso J, Picconi B Nat Neurosci. 2016; 19(7):868-75.

PMID: 27351172 DOI: 10.1038/nn.4306.


Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases.

Ni Z, Chen R Transl Neurodegener. 2015; 4:22.

PMID: 26579223 PMC: 4647804. DOI: 10.1186/s40035-015-0045-x.